N-(4-(4-(3-(3-tert-Butyl-1-m-tolyl-1H-pyrazol-5-yl)ureido)phenylamino)quinazolin-6-yl)propionamide

ID: ALA510516

PubChem CID: 44186427

Max Phase: Preclinical

Molecular Formula: C32H34N8O2

Molecular Weight: 562.68

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CCC(=O)Nc1ccc2ncnc(Nc3ccc(NC(=O)Nc4cc(C(C)(C)C)nn4-c4cccc(C)c4)cc3)c2c1

Standard InChI:  InChI=1S/C32H34N8O2/c1-6-29(41)35-23-14-15-26-25(17-23)30(34-19-33-26)36-21-10-12-22(13-11-21)37-31(42)38-28-18-27(32(3,4)5)39-40(28)24-9-7-8-20(2)16-24/h7-19H,6H2,1-5H3,(H,35,41)(H,33,34,36)(H2,37,38,42)

Standard InChI Key:  FQVDDJWQBNAYCH-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 42 46  0  0  0  0  0  0  0  0999 V2000
    2.6937   -5.9093    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4797   -5.6562    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.9652   -6.3242    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.4763   -6.9942    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6939   -6.7339    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4929   -7.8198    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2161   -8.2184    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7861   -8.2470    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2861   -7.5902    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0258   -5.4238    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.3081   -5.8306    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5959   -5.4126    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.3021   -6.6564    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1222   -5.8203    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8329   -5.4014    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5505   -5.8084    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5570   -6.6351    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8397   -7.0530    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1250   -6.6436    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2746   -7.0438    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2795   -7.8696    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2894   -9.5160    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5694   -9.1029    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5677   -8.2792    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0026   -9.0981    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9935   -8.2770    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6987   -7.8604    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4136   -8.2636    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4188   -9.0878    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7129   -9.5007    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8897   -4.9394    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7131   -4.9377    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1231   -4.2218    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7073   -3.5073    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8772   -3.5132    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4710   -4.2297    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9489   -4.2189    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1254   -7.8449    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1186   -7.0191    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8229   -6.6004    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4001   -6.6121    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6883   -7.0308    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 10  1  0
 20 21  1  0
 21 26  2  0
  5  1  2  0
 25 22  2  0
 10 11  1  0
 22 23  1  0
  1  2  1  0
 23 24  2  0
 24 21  1  0
 11 12  1  0
  4  6  1  0
 25 26  1  0
 11 13  2  0
 26 27  1  0
 27 28  2  0
 12 14  1  0
 28 29  1  0
  6  7  1  0
 29 30  2  0
 30 25  1  0
 14 15  2  0
  2 31  1  0
  2  3  1  0
 31 32  2  0
 15 16  1  0
 32 33  1  0
  6  8  1  0
 33 34  2  0
 16 17  2  0
 34 35  1  0
  3  4  2  0
 35 36  2  0
 36 31  1  0
 17 18  1  0
 33 37  1  0
  6  9  1  0
 28 38  1  0
 18 19  2  0
 38 39  1  0
 19 14  1  0
 39 40  2  0
  4  5  1  0
 39 41  1  0
 17 20  1  0
 41 42  1  0
M  END

Associated Targets(Human)

MAPK14 Tchem MAP kinase p38 alpha (12866 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SRC Tclin Tyrosine-protein kinase SRC (10310 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PC-3 (62116 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DU-145 (51482 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KIT Tclin Stem cell growth factor receptor (10667 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ABL1 Tclin Tyrosine-protein kinase ABL (18331 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

SRC Tyrosine-protein kinase SRC (482 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 562.68Molecular Weight (Monoisotopic): 562.2805AlogP: 7.16#Rotatable Bonds: 7
Polar Surface Area: 125.86Molecular Species: NEUTRALHBA: 7HBD: 4
#RO5 Violations: 2HBA (Lipinski): 10HBD (Lipinski): 4#RO5 Violations (Lipinski): 2
CX Acidic pKa: 11.57CX Basic pKa: 4.20CX LogP: 7.16CX LogD: 7.16
Aromatic Rings: 5Heavy Atoms: 42QED Weighted: 0.17Np Likeness Score: -1.90

References

1. Getlik M, Grütter C, Simard JR, Klüter S, Rabiller M, Rode HB, Robubi A, Rauh D..  (2009)  Hybrid compound design to overcome the gatekeeper T338M mutation in cSrc.,  52  (13): [PMID:19462975] [10.1021/jm9002928]
2. Klüter S, Grütter C, Naqvi T, Rabiller M, Simard JR, Pawar V, Getlik M, Rauh D..  (2010)  Displacement assay for the detection of stabilizers of inactive kinase conformations.,  53  (1): [PMID:19928858] [10.1021/jm901297e]
3. Richters A, Ketzer J, Getlik M, Grütter C, Schneider R, Heuckmann JM, Heynck S, Sos ML, Gupta A, Unger A, Schultz-Fademrecht C, Thomas RK, Bauer S, Rauh D..  (2013)  Targeting gain of function and resistance mutations in Abl and KIT by hybrid compound design.,  56  (14): [PMID:23773153] [10.1021/jm4004076]

Source